Neochromosome Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Neochromosome General Information

Description

Developer of genome-scale synthetic biology technology designed to enable biological engineering. The company's platform provides automated deoxyribonucleic acid synthesis, de novo chromosome engineering, and cellular delivery capabilities, enabling researchers and life science organizations to develop novel therapeutics, sustainable products, and advanced biological research with precision at the genomic scale.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 45-18 Court Square West, Queens
  • New York, NY 11101
  • United States
Primary Industry
Biotechnology
Parent Company
Corporate Office
  • 45-18 Court Square West, Queens
  • New York, NY 11101
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neochromosome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
7. Merger/Acquisition 01-Mar-2021 Completed Generating Revenue
6. Grant 02-May-2020 Completed Generating Revenue
5. Grant 01-Jan-2020 Completed Generating Revenue
4. Accelerator/Incubator 18-Oct-2019 Completed Generating Revenue
3. Grant 14-May-2018 Completed Generating Revenue
2. Grant 01-May-2018 $150K $100K Completed Generating Revenue
1. Accelerator/Incubator 13-Jun-2017 $100K $100K Completed Generating Revenue
To view Neochromosome’s complete valuation and funding history, request access »

Neochromosome Patents

Neochromosome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4208565-A1 Methods and systems for nucleic acid synthesis Inactive 01-Sep-2020
EP-4208565-A4 Methods and systems for nucleic acid synthesis Inactive 01-Sep-2020
US-20230053916-A1 Methods and systems for nucleic acid synthesis Inactive 01-Sep-2020
WO-2022051369-A1 Methods and systems for nucleic acid synthesis Inactive 01-Sep-2020
US-10865417-B2 Yeast synthetic biology platform for identifying shikimate pathway enzyme inhibitors Active 06-Apr-2018 C12N15/81
To view Neochromosome’s complete patent history, request access »

Neochromosome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neochromosome Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria LaunchLabs Accelerator/Incubator Minority
Endless Frontier Labs Accelerator/Incubator Minority
National Institute Of Allergy and Infectious Diseases Government
National Institutes of Health Government
To view Neochromosome’s complete investors history, request access »

Neochromosome FAQs

  • When was Neochromosome founded?

    Neochromosome was founded in 2015.

  • Where is Neochromosome headquartered?

    Neochromosome is headquartered in New York, NY.

  • What is the size of Neochromosome?

    Neochromosome has 42 total employees.

  • What industry is Neochromosome in?

    Neochromosome’s primary industry is Biotechnology.

  • Is Neochromosome a private or public company?

    Neochromosome is a Private company.

  • What is Neochromosome’s current revenue?

    The current revenue for Neochromosome is .

  • How much funding has Neochromosome raised over time?

    Neochromosome has raised $100K.

  • Who are Neochromosome’s investors?

    Alexandria LaunchLabs, Endless Frontier Labs, National Institute Of Allergy and Infectious Diseases, and National Institutes of Health have invested in Neochromosome.

  • When was Neochromosome acquired?

    Neochromosome was acquired on 01-Jan-2025.

  • Who acquired Neochromosome?

    Neochromosome was acquired by OpenTrons.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process